- Home
- ELLO vs FENC Comparison
ELLO vs FENC Comparison
Compare ELLO & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELLO
- FENC
- Stock Information
- Founded
- ELLO 1987
- FENC 1996
- Country
- ELLO Israel
- FENC United States
- Employees
- ELLO N/A
- FENC N/A
- Industry
- ELLO Electric Utilities: Central
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELLO Utilities
- FENC Health Care
- Exchange
- ELLO Nasdaq
- FENC Nasdaq
- Market Cap
- ELLO 208.2M
- FENC 222.9M
- IPO Year
- ELLO 1995
- FENC 2001
- Fundamental
- Price
- ELLO N/A
- FENC $8.40
- Analyst Decision
- ELLO
- FENC Strong Buy
- Analyst Count
- ELLO 0
- FENC 2
- Target Price
- ELLO N/A
- FENC $13.00
- AVG Volume (30 Days)
- ELLO 4.7K
- FENC 80.0K
- Earning Date
- ELLO 06-30-2025
- FENC 08-12-2025
- Dividend Yield
- ELLO N/A
- FENC N/A
- EPS Growth
- ELLO N/A
- FENC N/A
- EPS
- ELLO 0.43
- FENC N/A
- Revenue
- ELLO $44,405,534.00
- FENC $30,912,000.00
- Revenue This Year
- ELLO N/A
- FENC $0.85
- Revenue Next Year
- ELLO N/A
- FENC $55.16
- P/E Ratio
- ELLO $45.19
- FENC N/A
- Revenue Growth
- ELLO N/A
- FENC N/A
- 52 Week Low
- ELLO $11.30
- FENC $3.96
- 52 Week High
- ELLO $20.81
- FENC $8.88
- Technical
- Relative Strength Index (RSI)
- ELLO 61.85
- FENC 63.33
- Support Level
- ELLO $16.61
- FENC $7.94
- Resistance Level
- ELLO $18.54
- FENC $8.51
- Average True Range (ATR)
- ELLO 0.89
- FENC 0.41
- MACD
- ELLO 0.31
- FENC -0.01
- Stochastic Oscillator
- ELLO 77.96
- FENC 89.80
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is focused on the utility sector. It is an Israeli public company, which focuses its business in the energy and infrastructure sectors. The company's operating segment includes Photovoltaic power plants (PV Plants); Dorad Energy Ltd. (Dorad); Groen Gas Goor B.V. and a Pumped storage hydro power plant (Manara). It generates maximum revenue from the Dorad segment. Geographically, it derives a majority of its revenue from Spain.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.